Dela Rosa, Porferio I.
HRN: 23-55-28 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2023
LEVOFLOXACIN 500MG (TAB)
11/23/2023
11/29/2023
IVTT
500mg
Q24h
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Cardiovascular Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes